Pfizer is fighting for 8 cancer breakthroughs by 2030. We're driving the breakthroughs of tomorrow while fighting against cancer today. The fight takes all of us. Start by answering a few questions to understand your own cancer risks at PfizerForAll.com. Get started

At Pfizer our biotechnology is our foundation. With 25,000 clinical researchers testing everyday, pharmaceutical development and innovation are our focus. Learn more.

2025年2月4日 · Pfizer delivered strong fourth quarter and full-year 2024 financial results, demonstrating the company’s continued focus on commercial execution. Full-year 2024 revenues were $63.6 billion, representing 7% year-over-year operational growth, while fourth-quarter revenues were $17.8 billion, reflecting 21% year-over-year operational growth.

We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place. It was Charles Pfizer’s vision at the beginning and it holds true today.

We’ve transformed growth and development at Pfizer to ensure that everyone can follow a path to their dream career, whether that’s climbing a traditional ladder or “zig-zagging” their way to a new role.

Pfizer’s mission and vision is better known as Pfizer’s purpose, which is Breakthroughs That Change Patients’ Lives. What are Pfizer’s core values? Pfizer culture is driven by four core values: courage, excellence, equity, and joy.

From potential gene therapies to COVID-19 vaccines, learn more about Pfizer’s manufacturing and distribution supply chain and our commitment to product quality and sustainability.

2024年6月24日 · Pfizer was founded with the dream to deliver medicines and vaccines that would have positive impacts on global health. Nearly two centuries later, Pfizer has been at the forefront of medical and pharmaceutical breakthroughs that have not only helped to change patient lives, but shaped history.

2024年8月16日 · NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vaccine candidate against influenza and COVID-19 in healthy individuals 18-64 years of age. The ...

2024年2月29日 · We're elevating our breakthroughs in a bold new way on Pfizer.com. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development!